Expert Consult Series in Multiple Sclerosis
Updates, Clinical Scenarios, and Future Directions
Clinical Practice Guidelines
Practice guideline update summary: vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Farez MF, Correale J, Armstrong MJ, et al. Neurology. 2019;93(13):584-594.
COVID-19 vaccine guidance for people living with MS.
National Multiple Sclerosis Society.
Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A, Day GS, Marrie RA, et al. Neurology. 2018;90(17):777-788.
Patient and Caregiver Resources
Consortium of Multiple Sclerosis Centers
Multiple Sclerosis Association of America
National Multiple Sclerosis Society
Suggested Readings
Infectious complications of multiple sclerosis therapies: implications for screening, prophylaxis, and management.
Epstein DJ, Dunn J, Deresinski S. Open Forum Infect Dis. 2018;5(8):ofy174.
Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm.
Giovannoni G. Curr Opin Neurol. 2018;31(3):233-243.
Ofatumumab versus teriflunomide in multiple sclerosis.
Hauser SL, Bar-Or A, Cohen JA, et al. N Engl J Med. 2020;383(6):546-557.
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.
Hauser SL, Bar-Or A, Comi G, et al. N Engl J Med. 2017;376(3):221-234.
Treatment of multiple sclerosis: a review.
Hauser SL, Cree BAC. Am J Med. 2020;133(12):1380-1390.e2.
The role of infections in multiple sclerosis.
Marrodan M, Alessandro L, Farez MF, Correale J. Mult Scler. 2019;25(7):891-901.
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: a Delphi consensus statement.
Moiola L, Barcella V, Benatti S, et al. Mult Scler. 2021;27(3):331-346.
Infection mitigation strategies for multiple sclerosis patients on oral and monoclonal disease-modifying therapies.
Smith TE, Kister I. Curr Neurol Neurosci Rep. 2021;21(7):36.
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
Tsantes E, Curti E, Ganazzoli C, et al. J Neurol. 2020;267(9):2642-2647.
Relevant Resources
Screening, Imaging, and Emerging Treatment Strategies
Improved Diagnostic and Management Strategies
Overcoming Diagnostic Challenges, Targeting Remission, and Optimizing Cardiometabolic Health
New Approaches to Optimizing Patient Outcomes
Overcoming Diagnostic Barriers and Optimizing Long-Term Patient Outcomes
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Accelerating Diagnosis, Achieving Remission, and Encouraging Adherence
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Managing Patients Across the Disease Spectrum
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Best Practices for Emergency Care
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
The PCP’s Role in Timely Recognition and Referral
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Improving Patient Outcomes Through Shared Clinical Decision Making
Mechanistic Insights and Evolving Treatment Options
Clinical Resource Center
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
A PrEP Primer
A Foundation for Managed Care
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
What the Pharmacist Needs to Know about PrEP
Unlocking Novel Paths to Patient Care
Early Diagnosis to Ongoing Collaborative Care
The Increasing Role of JAK Inhibitors
Finding the Way Forward
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
Getting on the Fast Track to Identify AxSpA
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema
Reducing LDL-C and a Lifetime of Cardiovascular Risk
A Multidisciplinary Look at Early Diagnosis and Management
New Management Paradigms for Patients and Healthcare Systems
Best Practices for Diagnosis and Management
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
Are You Aware of New Blood-Based Multi-Cancer Screening Tools
Debates and Discussions About Diagnosis, New Therapies, and Health Care Delivery
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Strengthening Your Knowledge of Blood-Based Screening Tools
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
